Skip to main content
PIRAMAL PHARMA LIMITED logo

PIRAMAL PHARMA LIMITED — Investor Relations & Filings

Ticker · PPLPHARMA ISIN · INE0DK501011 LEI · 3358006D6AL7PZ4U9T51 BSE.NS Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2023-11-27 Regulatory Filings
Country IN India
Listing BSE.NS PPLPHARMA

About PIRAMAL PHARMA LIMITED

https://www.piramalpharma.com/

Piramal Pharma Limited provides a broad range of products and services across the drug lifecycle through three main business segments: Piramal Pharma Solutions, Piramal Critical Care, and Consumer Healthcare. Piramal Pharma Solutions operates as an integrated Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from drug discovery and development to commercial manufacturing of APIs and formulations. Piramal Critical Care focuses on complex hospital generics, holding a significant global market share in inhalation anesthetics, including Sevoflurane and Isoflurane, as well as injectable anesthesia and pain management therapies. The Consumer Healthcare division manages a diverse portfolio of over-the-counter brands such as Saridon, Lacto Calamine, and Tetmosol. The company leverages an extensive global manufacturing network to deliver specialized healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The document does not contain any financial data, detailed presentations, or reports. It is essentially an announcement of upcoming investor meetings, not the meetings' content or transcripts. The length is only 1579 characters, which is quite short and fits the pattern of a regulatory announcement rather than a full report or transcript. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides dates and venues for upcoming investor interactions. There is no financial data, report content, or detailed presentation included. The document is essentially an announcement of upcoming investor meetings, not a report or transcript itself. Given the nature and length of the document, it fits best under the category of Investor Presentation (IP) announcements or related updates. However, since it is only an intimation of the schedule and not the presentation itself, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement about investor meetings under SEBI regulations.
2023-11-21 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is an intimation to stock exchanges regarding details of litigation filed by a subsidiary of the company. It references compliance with SEBI Listing Regulations and provides a summary of the litigation case, including parties involved, forum, dispute details, and financial implications. The document is a regulatory announcement about legal proceedings rather than a full legal proceedings report or a financial report. It does not contain comprehensive financial data or detailed legal analysis but serves as an update on a significant legal matter as required by regulation. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is 3557 characters, which is consistent with a detailed announcement but not a full report or filing.
2023-11-21 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the successful closure of a US FDA inspection at a manufacturing facility. It references a previous letter and provides an update on regulatory compliance. The document is brief (1475 characters) and serves as an announcement rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed audit information. It is a regulatory announcement under SEBI regulations about an operational event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of analyst and institutional investor meetings. It references SEBI regulations and provides dates and venues for upcoming investor interactions. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content typical of financial reports or filings. The document is essentially an announcement of scheduled meetings, not a report or transcript. Given its short length (1532 characters) and nature as an informational notice, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication (1426 characters) addressed to stock exchanges, referencing a transcript of a conference call on financial results for the quarter and half year ended 30th September 2023. It states that the transcript is available on the company's website and is being provided pursuant to SEBI regulations. The document itself does not contain the transcript or financial data but is an announcement of the availability of the transcript. According to the 'Menu vs Meal' rule, such a short notice announcing the availability of a report or transcript should be classified as a Regulatory Filing (RNS) rather than the actual Call Transcript (CT).
2023-10-31 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.